Women with fatty liver urged not to skip cervical cancer screening

Doctors are advising women diagnosed with fatty liver disease to prioritise cervical cancer screening as part of their routine healthcare. Fatty liver, now often called metabolic dysfunction-associated steatotic liver disease (MASLD), is increasingly seen in women due to rising rates of obesity, diabetes, and metabolic syndrome. While fatty liver itself is not a direct cause of cervical cancer, experts warn that women focused on managing metabolic problems may neglect gynaecological check-ups.

Dr Neha Jain, Senior Consultant at Fortis LaFemme, said fatty liver should be a reminder to assess overall metabolic and preventive health, and that cervical cancer screening should remain a routine part of care. Cervical cancer is largely preventable when precancerous changes are detected early through Pap smears or HPV tests. Screening recommendations vary by age: women aged 21, 29 may need a Pap smear at regular intervals, while those 30, 65 may require HPV testing or a combined test.

Women who have missed screenings or have risk factors such as abnormal Pap results, HPV infection, or weakened immunity should consult a gynaecologist. Lifestyle changes including weight management, exercise, a balanced diet, and HPV vaccination can also support overall health. The key message is that metabolic and gynaecological care should go hand in hand.